InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-22.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Smith Jason Drew. Director active across 1 company, notably UroGen Pharma Ltd.. Aggregated, 15 disclosures have been recorded. Split: 1 buy · 2 sells. Total volume traded: €94k. History available since 17 May 2021. The latest transaction was disclosed on 8 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Smith Jason Drew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
3,334 股Ordinary SharesSEC:0001437749-26-029963:0
1,519 股@ US$42.54Ordinary SharesSEC:0001437749-26-029963:1
5,500 股Ordinary SharesSEC:0001437749-26-003778:0
3,333 股Ordinary SharesSEC:0001437749-25-028705:0
16,500 股Ordinary SharesSEC:0001437749-25-023963:0
2,500 股Ordinary SharesSEC:0001437749-25-002685:0
3,333 股Ordinary SharesSEC:0001437749-24-029038:0
417 股@ US$15.788.6% 占其流量Ordinary SharesSEC:0001437749-24-003155:0
834 股Ordinary SharesSEC:0001437749-24-003018:0
8,334 股Ordinary SharesSEC:0001437749-23-025204:0
833 股Ordinary SharesSEC:0001437749-23-002338:0
8,333 股Ordinary SharesSEC:0001437749-22-021776:0
833 股Ordinary SharesSEC:0001209191-22-006387:0
8,333 股Ordinary SharesSEC:0001209191-21-067440:0
2,500 股@ US$15.7184.1% 占其流量Common StockSEC:0001209191-21-033399:0
标准退出：2021年8月15日 (T+90)
15 条申报中的 15 条
About Smith Jason Drew
Smith Jason Drew is a declarant linked to UroGen Pharma Ltd. (XNAS), where he is General Counsel. He has 13 filings in total, and across the 13 sampled filings between 2021-05-18 and 2026-02-11, the reported amounts are EUR 32307 in buys and EUR 6091 in sells, with Levée d'options as the most frequent transaction nature.
